Connection

John O'Bryan to Carcinoma, Pancreatic Ductal

Back to Details
This is a "connection" page, showing publications John O'Bryan has written about Carcinoma, Pancreatic Ductal.
John O'Bryan
Connection Strength
0.696
Carcinoma, Pancreatic Ductal
  1. Targeting the KRAS a4-a5 allosteric interface inhibits pancreatic cancer tumorigenesis. Small GTPases. 2022 Jan; 13(1):114-127.
    View in: PubMed
    Score: 0.696
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.